High-Grade Bond Market Kicks Off Busy Sales Day

China’s Junshi Nabs FDA Approval in Rare Success for US Foray

A Doctor With Brain Cancer Is Helping Transform Its Treatment

Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion

Ozempic Could Be The Next Target of Medicare Price Negotiations

China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US

Pfizer Misses Quarterly Sales Estimates, Lowering Outlook

White House Asks Walgreens, CVS, Walmart for Help Promoting Drug-Cost Law

Drug Companies Are Minting Billions on Unproven Treatments With FDA Shortcut